|
Summary
In summary, this case exhibited the classic findings of an M4Eo variant. An alert flow cytometrist should have the ability to correlate morphology with the characteristic marker pattern and suggest cytogenetic and/or FISH analysis for the characteristic translocation.
References
-
Adriaansen
HJ, te Boekhorst PA, Hagemeijer AM, van der Schoot CE, Delwel HR, van Dongen
JJ. Acute myeloid leukemia M4 with bone marrow eosinophilia (M4Eo) and
inv(16)(p13q22) exhibits a specific immunophenotype with CD2 expression.
Blood. 1993 Jun 1;81(11):3043-51.
-
Haferlach
T, Winkemann M, Loffler H, Schoch R, Gassmann W, Fonatsch C, Schoch C,
Poetsch M, Weber-Matthiesen K, Schlegelberger B. The abnormal eosinophils
are part of the leukemic cell population in acute leukemia with abnormal
eosinophils (AML M4Eo) and carry the pericentric inversion 16: a combination
of May-Grunwald-Giemsa staining and fluorescence in situ hybridization.
Blood. 1996 Mar 15;87(6):2459-63.
-
Guerrasio
A, Pilatrino C, De Micheli D, Cilloni D, Serra A, Gottardi E, Parziale A,
Marmont F, Diverio D, Divona M, Lo Coco F, Saglio G. Assessment of minimal
residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by
qualitative and quantitative RT-PCR amplification of fusion transcripts.
Leukemia. 2002 Jun;16(6):1176-81.
-
Grimwade
D, Walker H, Harrison G, Oliver F, Chatters S, Harrison CJ, Wheatley K,
Burnett AK, Goldstone AH; Medical Research Council Adult Leukemia Working
Party. The predictive value of hierarchical cytogenetic classification in
older adults with acute myeloid leukemia (AML): analysis of 1065 patients
entered into the United Kingdom Medical Research Council AML11 trial. Blood.
2001 Sep 1;98(5):1312-20.
|